{
    "organizations": [],
    "uuid": "c975daed8968971d90e9bf31375518049a081088",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zhenxing-biopharmaceutical-chemica/brief-zhenxing-biopharmaceutical-chemical-unit-receives-approval-for-drug-clinical-trial-idUSL3N1RO3MS",
    "ord_in_thread": 0,
    "title": "BRIEF-Zhenxing Biopharmaceutical & Chemical unit receives approval for drug clinical trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 11(Reuters) - Zhenxing Biopharmaceutical & Chemical Co Ltd\n* Says coâ€™s Guangdong-based wholly owned biopharmaceutical unit received approval for drug clinical trial for Human Fibrinogen, from China Food and Drug Administration\nSource text in Chinese: goo.gl/9eN1Q8\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-11T16:12:00.000+03:00",
    "crawled": "2018-04-12T14:13:58.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "zhenxing",
        "biopharmaceutical",
        "chemical",
        "co",
        "ltd",
        "say",
        "co",
        "wholly",
        "owned",
        "biopharmaceutical",
        "unit",
        "received",
        "approval",
        "drug",
        "clinical",
        "trial",
        "human",
        "fibrinogen",
        "china",
        "food",
        "drug",
        "administration",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}